Quarterly report [Sections 13 or 15(d)]

Note 7 - Stockholders' Equity (Tables)

v3.26.3
Note 7 - Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2026
Notes Tables  
Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]
   

Number of

   

Weighted

 
   

Units and

   

Average Grant

 
   

Awards

   

Date Fair Value

 

Unvested balance at December 31, 2025

    235,400     $ 3.19  

Vested

    (200 )     85.50  

Vested - settlement deferred

    (235,000 )     2.46  

Unvested balance at September 30, 2026

    200     $ 85.50  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
                   

Weighted

         
                   

Average

         
           

Weighted

   

Remaining

   

Aggregate

 
   

Number

   

Average

   

Contractual

   

Intrinsic Value

 
   

of Options

   

Exercise Price

   

Term (years)

   

(in thousands)

 

Outstanding at December 31, 2025

    256,474     $ 9.74       8.6     $ —  

Outstanding at September 30, 2026

    256,474     $ 9.74       7.9     $ —  

Expected to vest

    78,452     $ 2.94       8.0     $ —  

Exercisable

    178,022     $ 12.73       7.8     $ —  
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
   

For the Three Months Ended

   

For the Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2026

   

2025

   

2026

   

2025

 

Research and development

  $ 9     $ 31     $ 38     $ 102  

General and administrative

    38       132       131       421  

Total stock-based compensation expense

  $ 47     $ 163     $ 169     $ 523  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
                           

Weighted

 
           

Weighted

           

Average

 
           

Average

   

Aggregate

   

Remaining

 
           

Exercise

   

Intrinsic Value

   

Contractual Life

 
   

Warrants

   

Price

   

(in thousands)

   

(in years)

 

Outstanding, December 31, 2025

    772,741     $ 10.56     $ —       3.3  

Expired

    (10 )     0.11       —       —  

Outstanding, September 30, 2026

    772,731     $ 10.56     $ —       2.5